On Monday, Emergent Biosolutions Inc (EBS) stock saw a modest uptick, ending the day at $8.6 which represents a slight increase of $0.88 or 11.40% from the prior close of $7.72. The stock opened at $8 ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 3.93% of ...

Narcan Sales: $95 million, reflecting strong volume in the US public interest channel ... 2024 Full Year Adjusted EBITDA Guidance: Raised to $180 to $200 million. Emergent BioSolutions Inc (NYSE:EBS) ...